Roflumilast N-oxide

Roflumilast N-oxide

CAT N°: 33975
Price:

From €94.00 €79.90

Roflumilast N-oxide is an inhibitor of phosphodiesterase 4 (PDE4; IC50 = 2 nM) and an active metabolite of the PDE4 inhibitor roflumilast (Item No. 15141).{49692} It is selective for PDE4 over PDE1-3 and PDE5 (IC50s = >10,000 nM for all). It reduces TNF-?-induced ICAM-1 and eotaxin levels when used in combination with prostaglandin E2 (PGE2; Item No. 14010) in GM06114 human fetal lung fibroblasts (IC50s = 0.9 and 0.5 nM, respectively).{61405} It also reduces bFGF-induced and IL-1? augmented proliferation in the same cells. Roflumilast N-oxide (2 nM) reverses cigarette smoke extract-induced reductions in ciliary beat frequency in isolated human bronchial epithelial cells.{61406} Roflumilast N-oxide also increases plasma glucagon-like peptide 1 (GLP-1) levels in a glucose challenge in diabetic db/db mice when administered at a dose of 10 mg/kg, as well as prevents increases in blood glucose in db/db mice at 3 mg/kg per day.{61407}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 3-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxido-4-pyridinyl)-4-(difluoromethoxy)-benzamide
  • Correlated keywords
    • PDE 1 2 3 4 5 ICAM1 IL1? RNO
  • Product Overview:
    Roflumilast N-oxide is an inhibitor of phosphodiesterase 4 (PDE4; IC50 = 2 nM) and an active metabolite of the PDE4 inhibitor roflumilast (Item No. 15141).{49692} It is selective for PDE4 over PDE1-3 and PDE5 (IC50s = >10,000 nM for all). It reduces TNF-?-induced ICAM-1 and eotaxin levels when used in combination with prostaglandin E2 (PGE2; Item No. 14010) in GM06114 human fetal lung fibroblasts (IC50s = 0.9 and 0.5 nM, respectively).{61405} It also reduces bFGF-induced and IL-1? augmented proliferation in the same cells. Roflumilast N-oxide (2 nM) reverses cigarette smoke extract-induced reductions in ciliary beat frequency in isolated human bronchial epithelial cells.{61406} Roflumilast N-oxide also increases plasma glucagon-like peptide 1 (GLP-1) levels in a glucose challenge in diabetic db/db mice when administered at a dose of 10 mg/kg, as well as prevents increases in blood glucose in db/db mice at 3 mg/kg per day.{61407}

We also advise you

Any project? Any challenge? We are in!
Contact us

Headquarters:
Parc d’activités du Pas du Lac
10 bis avenue Ampère

78180 Montigny le Bretonneux
France

Call us
Information
My account
Follow us

Copyright © 2024 BERTIN BIOREAGENT. All rights reserved | Terms & conditions

Secure payment
Subscribe to our newsletter